enkephalin, leucine has been researched along with Nerve Degeneration in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (30.77) | 18.7374 |
1990's | 6 (23.08) | 18.2507 |
2000's | 11 (42.31) | 29.6817 |
2010's | 1 (3.85) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, KL; Faull, RL; Glass, M; Waldvogel, HJ | 1 |
Carboni, E; Carta, AR; Frau, L; Garau, A; Ibba, M; Schintu, N | 1 |
Abbruscato, TJ; Karamyan, VT; Shah, K; Wang, H; Yang, L | 1 |
Alberch, J; Bosch, M; Canals, JM; Ernfors, P; Martín-Ibañez, R; Mengod, G; Muñoz, MT; Pineda, JR; Torres-Peraza, JF | 1 |
Ariano, MA; Buchanan, TM; Collier, TJ; Elsworth, JD; Grissell, AE; Littlejohn, FC; Steece-Collier, K | 1 |
Ryan, AB; Scrable, H; Zeitlin, SO | 1 |
Herzog, H; Loacker, S; Sayyah, M; Schwarzer, C; Wittmann, W | 1 |
Hunt, SP; Kelly, JS; Ninkovic, M | 1 |
Emson, PC; Hunt, SP; Kelly, JS | 1 |
Agid, Y; Blanchard, V; Chritin, M; Feuerstein, C; Javoy-Agid, F; Raisman-Vozari, R; Savasta, M | 1 |
Cicchetti, F; Hayden, MR; Nasir, J; O'Kusky, JR; Parent, A | 1 |
Andersson, M; Cenci, MA; Hilbertson, A | 1 |
Alfonso, OF; Belayev, L; Friedman, LK; Ginsberg, MD | 1 |
Burgunder, JM; Humm, AM; Lauterburg, T; Pabst, C | 1 |
Andren, PE; Gunne, L; Svenningsson, P | 1 |
Abraham, KE; Brewer, KL; McGinty, JF | 1 |
Aguilar-Santelises, M; Bakalkin, G; Cebers, G; Gileva, I; Hauser, KF; Hoon Goh, B; Reznikov, K; Tan-No, K; Terenius, L; Yakovleva, T | 1 |
Fuxe, K; Goldstein, M; Hökfelt, T; Jonsson, G; Schwarcz, R; Terenius, L | 1 |
Dray, F; Gros, C; Llorens, C; Pollard, H; Schwartz, JC | 1 |
Kuhar, MJ; Synder, SH; Uhl, GR | 1 |
Kanazawa, I | 1 |
Besse, D; Besson, JM; Lombard, MC; Perrot, S | 1 |
Furness, JB; Krishnamurthy, S; Schuffler, MD; Wattchow, DA; Yoshida, MM | 1 |
Landis, DM; Marshall, PE; Zalneraitis, EL | 1 |
Ford, MJ; Meriney, SD; Oliva, D; Pilar, G | 1 |
Bodnar, RJ; Nilaver, G; Portzline, T | 1 |
26 other study(ies) available for enkephalin, leucine and Nerve Degeneration
Article | Year |
---|---|
Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
Topics: Aged; Aged, 80 and over; Brain Mapping; Cannabinoid Receptor Modulators; Down-Regulation; Enkephalins; Female; gamma-Aminobutyric Acid; Globus Pallidus; Humans; Huntington Disease; Immunohistochemistry; Male; Microscopy, Confocal; Middle Aged; Nerve Degeneration; Neuronal Plasticity; Neurons; Receptor, Cannabinoid, CB1; Receptors, GABA-A; Receptors, GABA-B; Substance P; Up-Regulation | 2009 |
Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson's disease.
Topics: Analysis of Variance; Animals; Brain; CD11b Antigen; Cell Count; Chromatography, High Pressure Liquid; Disease Models, Animal; Disease Progression; Dopamine; Electrochemistry; Enkephalins; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Locomotion; Male; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Olfactory Bulb; Parkinsonian Disorders; Time Factors; Tyrosine 3-Monooxygenase | 2009 |
Characterization of neuroprotective effects of biphalin, an opioid receptor agonist, in a model of focal brain ischemia.
Topics: Animals; Brain; Brain Edema; Brain Ischemia; Cell Size; Cells, Cultured; Disease Models, Animal; Drug Evaluation, Preclinical; Enkephalins; Hippocampus; Infarction, Middle Cerebral Artery; Male; Mice; Molecular Targeted Therapy; Motor Activity; Nerve Degeneration; Neuroprotective Agents; Protein Kinase C; Receptors, Opioid; Sodium-Potassium-Chloride Symporters; Stroke | 2011 |
Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.
Topics: Age of Onset; Animals; Ataxia; Brain-Derived Neurotrophic Factor; Cell Death; Cell Line, Transformed; Chorea; Corpus Striatum; Crosses, Genetic; Endocytosis; Enkephalins; Gene Expression Regulation; Huntingtin Protein; Huntington Disease; Mice; Mice, Knockout; Mice, Transgenic; Movement Disorders; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Phenotype; Stem Cells; Transfection; Trinucleotide Repeats | 2004 |
Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems.
Topics: Animals; Apoptosis; Caspase 3; Caspases; Corpus Striatum; Disease Models, Animal; Disease Progression; Dopamine; Efferent Pathways; Enkephalins; Enzyme Activation; Male; Mitochondrial Proteins; Nerve Degeneration; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase; Up-Regulation | 2005 |
Genetic interaction between expanded murine Hdh alleles and p53 reveal deleterious effects of p53 on Huntington's disease pathogenesis.
Topics: Alleles; Animals; Brain; Disease Models, Animal; Enkephalins; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Huntingtin Protein; Huntington Disease; Intranuclear Inclusion Bodies; Mice; Mice, Knockout; Mice, Transgenic; Mutation; Nerve Degeneration; Nerve Tissue Proteins; Nuclear Proteins; Peptides; Protein Precursors; RNA, Messenger; Tumor Suppressor Protein p53; Up-Regulation | 2006 |
Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzamides; Cell Count; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Epilepsy, Temporal Lobe; Guanidines; Hippocampus; Kindling, Neurologic; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphinans; Naltrexone; Nerve Degeneration; Piperazines; Protein Precursors; Receptors, Opioid, kappa; Synaptic Transmission; Time Factors | 2007 |
Effect of dorsal rhizotomy on the autoradiographic distribution of opiate and neurotensin receptors and neurotensin-like immunoreactivity within the rat spinal cord.
Topics: Afferent Pathways; Animals; Autoradiography; Axonal Transport; Dendrites; Enkephalin, Methionine; Enkephalins; Ganglia, Spinal; Immunoenzyme Techniques; Male; Microscopy, Electron; Nerve Degeneration; Neurons; Neurotensin; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Neurotensin; Receptors, Opioid; Spinal Cord | 1981 |
The electron microscopic localization of methionine-enkephalin within the superficial layers (I and II) of the spinal cord.
Topics: Afferent Pathways; Animals; Axons; Dendrites; Endorphins; Enkephalins; Ganglia, Spinal; Male; Microscopy, Electron; Nerve Degeneration; Rats; Spinal Cord; Synaptic Vesicles | 1980 |
DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration.
Topics: Animals; Binding Sites; Corpus Striatum; Denervation; Dopamine; Enkephalins; Immunohistochemistry; Male; Nerve Degeneration; Piperazines; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Tyrosine 3-Monooxygenase | 1996 |
Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene.
Topics: Afferent Pathways; Animals; Basal Ganglia; Enkephalins; Gene Targeting; Globus Pallidus; Heterozygote; Huntington Disease; Immunohistochemistry; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroglia; Neurons; Substance P; Synapses; Thalamic Nuclei | 1999 |
Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease.
Topics: Animals; Antisense Elements (Genetics); Bacterial Proteins; Biomarkers; Cell Count; Disease Models, Animal; Dyskinesias; Enkephalins; Female; Levodopa; Neostriatum; Nerve Degeneration; Neurons; Parkinsonian Disorders; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substantia Nigra; Transcription Factors; Ventral Tegmental Area | 1999 |
Distribution of glutamate and preproenkephalin messenger RNAs following transient focal cerebral ischemia.
Topics: Animals; Brain; Cerebral Infarction; Corpus Striatum; Down-Regulation; Enkephalins; Glutamic Acid; Ischemic Attack, Transient; Male; Neocortex; Nerve Degeneration; Neurons; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tissue Distribution | 2000 |
Enkephalin and aFGF are differentially regulated in rat spinal motoneurons after chemodenervation with botulinum toxin.
Topics: Age Factors; Animals; Botulinum Toxins; Cell Count; Corpus Striatum; Enkephalins; Female; Fibroblast Growth Factor 1; Fluorescent Dyes; Galanin; Gene Expression; Motor Neurons; Muscle Denervation; Muscle, Skeletal; Nerve Degeneration; Neuropeptide Y; Neurotensin; Rats; Rats, Wistar; RNA, Messenger; Spinal Cord; Stilbamidines; Substance P; Vasoactive Intestinal Peptide | 2000 |
L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset.
Topics: Animals; Benzazepines; Blotting, Western; Callithrix; Cerebral Cortex; Corpus Striatum; Denervation; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine Antagonists; Enkephalins; Gene Expression; Genes, Immediate-Early; Levodopa; Nerve Degeneration; Oxidopamine; Parkinson Disease; Protein Precursors; Proto-Oncogene Proteins c-fos; Raclopride; Radioligand Assay; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Substance P; Substantia Nigra; Sympatholytics; Tritium | 2000 |
The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury.
Topics: Animals; Behavior, Animal; Dynorphins; Enkephalins; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Grooming; Indans; Male; Nerve Degeneration; Neurons; Neurotoxins; Opioid Peptides; Pain; Pain Measurement; Protein Precursors; Quinoxalines; Rats; Rats, Long-Evans; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, Metabotropic Glutamate; RNA, Messenger; Spinal Cord; Spinal Cord Injuries | 2001 |
Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms.
Topics: Apoptosis; Cation Exchange Resins; Cell Compartmentation; Cell Survival; Central Nervous System; Cytoplasm; Cytotoxins; Dynorphins; Enkephalins; Immunohistochemistry; Lipids; Naloxone; Narcotic Antagonists; Nerve Degeneration; Peptide Fragments; Protein Precursors; Protein Structure, Tertiary; Receptors, Opioid; Receptors, Opioid, kappa; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study.
Topics: Animals; Brain; Choline O-Acetyltransferase; Corpus Striatum; Dopamine; Enkephalins; Fluorescent Antibody Technique; Glutamate Decarboxylase; Glutamates; Hippocampus; Ibotenic Acid; Kainic Acid; Male; Nerve Degeneration; Oxazoles; Rats; Serotonin; Substantia Nigra; Tyrosine 3-Monooxygenase | 1979 |
Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies.
Topics: Animals; Binding Sites; Corpus Striatum; Dopamine; Endorphins; Enkephalins; Hydroxydopamines; Kainic Acid; Nerve Degeneration; Neural Pathways; Neurons; Rats; Receptors, Dopamine; Receptors, Opioid; Substantia Nigra | 1978 |
Enkephalin-containing pathway: amygdaloid efferents in the stria terminalis.
Topics: Amygdala; Animals; Cerebral Ventricles; Efferent Pathways; Endorphins; Enkephalins; Nerve Degeneration; Nerve Fibers; Radioimmunoassay; Rats | 1978 |
On chorea: possible neuronal mechanisms.
Topics: Animals; Brain Mapping; Corpus Striatum; Dopamine; Enkephalins; gamma-Aminobutyric Acid; Humans; Huntington Disease; Macaca; Nerve Degeneration; Neural Pathways; Substantia Nigra | 1992 |
Regulation of opioid binding sites in the superficial dorsal horn of the rat spinal cord following loose ligation of the sciatic nerve: comparison with sciatic nerve section and lumbar dorsal rhizotomy.
Topics: Analgesics; Animals; Autoradiography; Benzeneacetamides; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Nerve Degeneration; Neurons, Afferent; Oligopeptides; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Sciatic Nerve; Spinal Cord | 1992 |
Megacolon in myotonic dystrophy caused by a degenerative neuropathy of the myenteric plexus.
Topics: Adult; Colon; Enkephalins; Histocytochemistry; Humans; Male; Megacolon; Myenteric Plexus; Myotonic Dystrophy; Nerve Degeneration; Nerve Fibers; Neuropeptide Y; Radiography; Substance P; Vasoactive Intestinal Peptide | 1988 |
Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
Topics: Adolescent; Adult; Aged; Brain; Caudate Nucleus; Corpus Striatum; Enkephalin, Leucine; Globus Pallidus; Humans; Huntington Disease; Immunoenzyme Techniques; Middle Aged; Nerve Degeneration; Neural Pathways; Neurons; Putamen; Substance P; Substantia Nigra | 1983 |
Endogenous opioids modulate neuronal survival in the developing avian ciliary ganglion.
Topics: Animals; Animals, Newborn; Cell Survival; Chick Embryo; Chickens; Embryonic and Fetal Development; Endorphins; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Ganglia, Parasympathetic; Mesencephalon; Morphine; Nerve Degeneration; Neuromuscular Junction; Neurons; Synapses; Synaptic Transmission | 1991 |
Differential alterations in opioid analgesia following neonatal monosodium glutamate treatment.
Topics: Analgesia; Animals; Animals, Newborn; Arcuate Nucleus of Hypothalamus; beta-Endorphin; Brain Chemistry; Dose-Response Relationship, Drug; Electroshock; Endorphins; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Female; Glutamates; Immunoenzyme Techniques; Nerve Degeneration; Rats; Rats, Inbred Strains; Reflex; Sodium Glutamate | 1985 |